Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Bull's Eye: Buy Glenmark Pharma, Capital First, Federal Bank; sell GSFC, CESC

      Sumeet Jain of Destimoney Securities advises buying Capital First with a target of Rs 766.

    • Here are SP Tulsian's top trading ideas

      In at interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on the fundamentals of the market and specific stocks.

    • Ujjivan Financial Services may test Rs 320-325: Hemant Thukral

      Hemant Thukral of Aditya Birla Money feels that Ujjivan Financial Services may test Rs 320-325.

    • Sell IOC; buy Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Aurobindo Pharma and Johnson Controls -Hitachi Air Conditioning India.

    • Buy Aurobindo Pharma, Dr Reddy's Laboratories; sell HPCL: Rajat Bose

      Rajat Bose of rajatkbose.com advises selling Hindustan Petroleum Corporation and suggests buying Aurobindo Pharma, Dr Reddy's Laboratories.

    • Buy, Sell, Hold: What stocks and sectors are on analysts' radar today?

      GAIL, Reliance and Reliance, among others, are being tracked by investors' radar.

    • See upside in Divis Laboratories, says Shahina Mukadam

      Shahina Mukadam, Independent Market Expert is of the view that one may hold Divis Laboratories.

    • Nifty may face resistance at 9724; 4 stocks to bet on today

      According to Prakash Gaba of prakashgaba.com, crucial support for the Nifty is at 9630-9580 and the resistance is at 9724 and he picks Hindustan Zinc, Nalco and TVS Motor as bullish plays and HDIL as a bearish play.

    • Here are SP Tulsian's top trading ideas

      In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

    • Buy Aurobindo Pharma, Techno Electric; sell Balrampur Chini: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one may buy Aurobindo Pharma and Techno Electric and sell Balrampur Chini.

    • Buy Balkrishna Industries, Uflex, PVR: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Balkrishna Industries, Uflex and PVR.

    • Buy Can Fin Homes, Aurobindo Pharma, Coromandel International: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Can Fin Homes, Coromandel International and Aurobindo Pharma.

    • Buy Apollo Tyres, Petronet, Adani Enterprises; sell Tata Motors: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Apollo Tyres, Petronet LNG and Adani Enterprises and sell Tata Motors and Aurobindo Pharma.

    • Here are some fundamental trading ideas from SP Tulsian

      In an interview to CNBC-TV18, SP Tulsian of sptulsian.com shared his readings and outlook on market and specific stocks.

    • Buy ICICI Bank, United Spirits: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy ICICI Bank and United Spirits.

    • Hold Aurobindo Pharma, advises Sandeep Wagle

      Sandeep Wagle of powermywealth.com recommends holding Aurobindo Pharma.

    • Hold Castrol India, says Rajesh Agarwal

      Rajesh Agarwal of AUM Capital suggests holding Castrol India and advises exiting Nectar Life Sciences.

    • Here are a few stock ideas by SP Tulsian

      In an interview to CNBC-TV18's Latha Venkatesh, Sonia Shenoy and Anuj Singhal, SP Tulsian of sptulsian.com shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Buy, Sell, Hold: 6 stocks that analysts are tracking today

      Aurobindo Pharma, Jagran Prakashan, an M&M, among others are being tracked by investors today.

    • Here are SP Tulsian's top trading ideas

      In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his readings and outlook on the market and specific stocks.

    • Buy Aurobindo Pharma, NTPC: Mitessh Thakkar

      Mitessh Thakkar of mitesshtakkar.com recommends buying Aurobindo Pharma and NTPC.

    • Buy Motherson Sumi, HDFC; sell Reliance Power: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Motherson Sumi and HDFC and sell Reliance Power, Reliance Infra and Reliance Capital.

    • Support for Nifty at 9540; buy Mahindra & Mahindra, NIIT Tech: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, Nifty has support at 9540 and resistance at 9660-9713 while Bank Nifty has support at 23000 and resistance at 23500.

    • Buy Wockhardt, Divis Laboratories, Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Wockhardt, Divis Laboratories and Aurobindo Pharma.

    • Positive on pharma; buy Dr Reddys, Cipla, Aurobindo: Rahul Arora

      In an interview to CNBC-TV18, Rahul Arora, CEO at Nirmal Bang Institutional Equities, shared his views on various stocks and sectors.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347